SGLT2i Trials: current synopsis.
Congress Presentation
About the speaker
Doctor Anselm Kai Gitt
3 more presentations in this session
Opening Remarks - The future of SGLT2 Inhibitor Cardiovascular Outcomes trials: what are we hoping to learn?
Speaker: Professor L. Leiter (Toronto, CA) Doctor A. Gitt (Ludwigshafen, DE)
Roundtable discussion: the future of SGLT2i CVOT trials: do we need more data? What are we hoping to learn.
Speaker: Professor L. Leiter (Toronto, CA) Doctor A. Gitt (Ludwigshafen, DE)
Closing remarks - The future of SGLT2 Inhibitor Cardiovascular Outcomes trials: what are we hoping to learn?
Speaker: Professor L. Leiter (Toronto, CA) Doctor A. Gitt (Ludwigshafen, DE)
Access the full session
The future of SGLT2 Inhibitor Cardiovascular Outcomes trials: what are we hoping to learn?
About the event
